[All-oral, interferon-free therapies for patients with chronic genotype 1 hepatitis C virus infection]

MeSH terms

• 2-Naphthylamine
• Administration, Oral
• Anilides / administration & dosage
• Anilides / adverse effects
• Antiviral Agents / administration & dosage*
• Antiviral Agents / adverse effects
• Benzimidazoles / administration & dosage
• Benzimidazoles / adverse effects
• Carbamates / administration & dosage
• Carbamates / adverse effects
• Clinical Trials, Phase III as Topic
• Dose-Response Relationship, Drug
• Drug Administration Schedule
• Drug Approval
• Drug Combinations
• Fluorenes / administration & dosage
• Fluorenes / adverse effects
• Genotype*
• Germany
• Hepacivirus / drug effects*
• Hepacivirus / genetics*
• Hepatitis C, Chronic / drug therapy*
• Hepatitis C, Chronic / virology*
• Humans
• Interferons / administration & dosage*
• Interferons / adverse effects
• Liver Cirrhosis / drug therapy
• Liver Cirrhosis / virology
• Proline
• Ribavirin / administration & dosage
• Ribavirin / adverse effects
• Ritonavir / administration & dosage
• Ritonavir / adverse effects
• Sofosbuvir
• Sulfonamides / administration & dosage
• Sulfonamides / adverse effects
• Uracil / administration & dosage
• Uracil / adverse effects
• Uracil / analogs & derivatives
• Uridine Monophosphate / administration & dosage
• Uridine Monophosphate / adverse effects
• Uridine Monophosphate / analogs & derivatives
• Valine